Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L3 pseudogene 3 (RPL3P3) is a pseudogene related to the functional ribosomal protein L3 gene (RPL3), which encodes a component of the large 60S subunit of the ribosome. RPL3P3 itself is a non-coding, non-functional genomic sequence that does not produce a protein product and is not considered a receptor, enzyme, or any kind of therapeutic target. Like many ribosomal protein genes, there are several processed pseudogenes (such as RPL3P3) dispersed throughout the genome, but they lack biological activity and clinical relevance. RPL3P3 is categorized as a pseudogene, which means it is a defunct copy of a gene that has lost its protein-coding potential and functional role through evolution. There is no evidence that RPL3P3 is involved in disease, targeted by drugs, serves as a biomarker, or presents any therapeutic relevance. The true functional target is "Ribosomal protein L3" (RPL3), not RPL3P3. Pseudogenes like RPL3P3 often appear in search results for gene names but are not actionable drug targets and do not encode active proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L3 pseudogene 3 (RPL3P3).